Search
for
Sort by
Research 151–180 of 1000+
- Clinical application of 5α-reductase inhibitors
- Polycystic ovary syndrome (PCOS)
- Thyroid hormone action in epidermal development and homeostasis and its implications in the pathophysiology of the skin
- Cardiovascular risk factors and events in women with androgen excess
- Endocrine disorders in Woodhouse-Sakati syndrome: a systematic review of the literature
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Does a male polycystic ovarian syndrome equivalent exist?
- Effect of finasteride in idiopathic hirsutism
- Hirsutism: diagnosis and treatment
- Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Anti-androgen Treatments
- Mutations in the vitamin D receptor gene in four patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets
- Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
- Cross-sex hormone therapy for gender dysphoria
- Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome
- A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
- Alterations of gut microbiota composition in post-finasteride patients: a pilot study
- Role of vitamin D and calcium signaling in epidermal wound healing
- Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
- Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.
- Lack of endocrine systemic side effects after topical application of spironolactone in man
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
- Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood
- Puberty induction with recombinant gonadotropin: What impact on future fertility?